A carregar...
Sequential application of a cytotoxic nanoparticle and a PI3K inhibitor enhances antitumor efficacy
Nanomedicines that preferentially deploy cytotoxic agents to tumors, and molecular targeted therapeutics that inhibit specific aberrant oncogenic drivers are emerging as the new paradigm for the management of cancer. While combination therapies are a mainstay of cancer chemotherapy, few studies have...
Na minha lista:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3946433/ https://ncbi.nlm.nih.gov/pubmed/24121494 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-12-3783 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|